drugset / Trial / NCT00167934

Determining Metabolic Effects of Valproate and Antipsychotic Therapy

NCT00167934

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will determine the metabolic processes responsible for high levels of blood glucose, metabolism disorders, and weight gain in people with schizophrenia who have been treated with antipsychotic medications in combination with valproate.

Timeline

Start
2004-12
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Valproate Small molecule 500 mg
Subject Valproate Small molecule 3000 mg

Indications